SG11201501681SA - Methods and compositions for producing induced hepatocytes - Google Patents

Methods and compositions for producing induced hepatocytes

Info

Publication number
SG11201501681SA
SG11201501681SA SG11201501681SA SG11201501681SA SG11201501681SA SG 11201501681S A SG11201501681S A SG 11201501681SA SG 11201501681S A SG11201501681S A SG 11201501681SA SG 11201501681S A SG11201501681S A SG 11201501681SA SG 11201501681S A SG11201501681S A SG 11201501681SA
Authority
SG
Singapore
Prior art keywords
compositions
methods
producing induced
induced hepatocytes
hepatocytes
Prior art date
Application number
SG11201501681SA
Inventor
Kamen P Simeonov
Hirdesh Uppal
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of SG11201501681SA publication Critical patent/SG11201501681SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/27—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from lung cells, from cells of the respiratory tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
SG11201501681SA 2012-09-07 2013-09-06 Methods and compositions for producing induced hepatocytes SG11201501681SA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261698359P 2012-09-07 2012-09-07
US201361777973P 2013-03-12 2013-03-12
PCT/US2013/058414 WO2014039768A1 (en) 2012-09-07 2013-09-06 Methods and compositions for producing induced hepatocytes

Publications (1)

Publication Number Publication Date
SG11201501681SA true SG11201501681SA (en) 2015-04-29

Family

ID=49209556

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201501681SA SG11201501681SA (en) 2012-09-07 2013-09-06 Methods and compositions for producing induced hepatocytes

Country Status (15)

Country Link
US (2) US20140087416A1 (en)
EP (1) EP2892999A1 (en)
JP (1) JP2015527084A (en)
KR (1) KR20150052228A (en)
CN (1) CN104781393A (en)
AU (1) AU2013312440A1 (en)
BR (1) BR112015005011A2 (en)
CA (1) CA2883714A1 (en)
HK (1) HK1212384A1 (en)
IL (1) IL237433A0 (en)
MX (1) MX2015002917A (en)
RU (1) RU2015107036A (en)
SG (1) SG11201501681SA (en)
WO (1) WO2014039768A1 (en)
ZA (1) ZA201501435B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828681B2 (en) 2012-01-13 2014-09-09 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US9023612B2 (en) 2012-01-13 2015-05-05 Bell Biosystems, Inc. Eukaryotic cells with artificial endosymbionts for multimodal detection
US10076579B2 (en) 2012-01-13 2018-09-18 Bell Biosystems, Inc. Host cells with artificial endosymbionts
US8956873B2 (en) 2012-01-13 2015-02-17 Bell Biosystems, Inc. Host cells with artificial endosymbionts
CN103981147B (en) 2013-02-08 2017-11-10 中国科学院上海生命科学研究院 A kind of new method for preparing hepatic parenchymal cells
AU2014315321A1 (en) 2013-09-03 2016-03-03 Bell Biosystems, Inc. Host cell modification with artificial endosymbionts
CN104830906B (en) * 2014-02-12 2018-09-04 北京维通达生物技术有限公司 A method of reprogramming obtains functional people's liver parenchymal cell
WO2015164228A1 (en) * 2014-04-21 2015-10-29 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
EP3169310A1 (en) 2014-07-15 2017-05-24 Life Technologies Corporation Compositions with lipid aggregates and methods for efficient delivery of molecules to cells
WO2016054298A1 (en) * 2014-10-01 2016-04-07 Bell Biosystems, Inc. Magnetogenetics
EP3359169A4 (en) * 2015-10-05 2019-03-13 Orig3N, Inc. Diagnosis and treatment of parkinson's disease based on identification and amelioration of liver dysfunction
SG11201810827VA (en) * 2016-06-03 2018-12-28 Stemgenics Inc Direct reprogramming of a human somatic cell to a selected (predetermined) differentiated cell with functionalized nanoparticles
KR101967435B1 (en) * 2016-07-28 2019-04-09 울산과학기술원 Composition for inducing direct conversion of somatic cell into hepatic stem cell, hepatic cell, or cholangiocyte
JP2019535272A (en) * 2016-11-16 2019-12-12 アリール バイオテクノロジー アンド ファーマシューティカルズ， インコーポレイテッド Induction of hepatocytes by stem cell differentiation with RNA
EP3808380A1 (en) * 2016-12-08 2021-04-21 CureVac AG Rna for treatment or prophylaxis of a liver disease
CN109504650A (en) * 2017-09-15 2019-03-22 海门雨霖细胞科技有限责任公司 Small molecule induction human fibroblasts directly reprogram the method for liver cell
US20210189347A1 (en) * 2017-10-23 2021-06-24 Kyushu University, National University Corporation Method for producing liver stem cells or liver progenitor cells by direct reprogramming
WO2020138208A1 (en) * 2018-12-26 2020-07-02 国立大学法人京都大学 Method for producing hepatocytes
EP3908297A4 (en) * 2019-01-11 2022-06-29 Figene, LLC Fibroblast regenerative cells
EP3931304A4 (en) * 2019-02-26 2022-10-19 Peking University Compositions and methods for reprograming non-hepatocyte cells into hepatocyte cells
CN114085874B (en) * 2022-01-10 2022-04-29 广东乾晖生物科技有限公司 Method for preparing immortalized liver cells with reversible liver functions and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2197915B (en) 1986-11-19 1990-11-14 Rolls Royce Plc Improvements in or relating to fluid bearings
US7282366B2 (en) 2000-04-27 2007-10-16 Geron Corporation Hepatocytes for therapy and drug screening made from embryonic stem cells
EP4174179A3 (en) 2005-08-23 2023-09-27 The Trustees of the University of Pennsylvania Rna containing modified nucleosides and methods of use thereof
US7989204B2 (en) 2006-04-28 2011-08-02 Viacyte, Inc. Hepatocyte lineage cells
US8062632B2 (en) * 2008-06-23 2011-11-22 National Yang-Ming University Systems and methods for making hepatocytes from extrahepatic somatic stem cells and use thereof
PL2510099T3 (en) 2009-12-07 2018-01-31 The Trustees Of Univ Of Pennsylvania Rna preparations comprising purified modified rna for reprogramming cells
WO2011102532A1 (en) * 2010-02-16 2011-08-25 国立大学法人九州大学 Induced hepatocytes
WO2011130402A2 (en) * 2010-04-13 2011-10-20 Cellular Dynamics International, Inc. Hepatocyte production by forward programming
CN102465115B (en) * 2010-11-04 2014-03-05 中国科学院上海生命科学研究院 Hepatocyte preparation method
CN102286535B (en) * 2011-06-17 2013-06-05 中国人民解放军第二军医大学 Method for transdifferentiation of fibroblasts into hepatic stem cells

Also Published As

Publication number Publication date
CN104781393A (en) 2015-07-15
AU2013312440A1 (en) 2015-03-19
MX2015002917A (en) 2015-06-03
IL237433A0 (en) 2015-04-30
BR112015005011A2 (en) 2018-04-17
HK1212384A1 (en) 2016-06-10
WO2014039768A1 (en) 2014-03-13
CA2883714A1 (en) 2014-03-13
US20140087416A1 (en) 2014-03-27
KR20150052228A (en) 2015-05-13
JP2015527084A (en) 2015-09-17
ZA201501435B (en) 2017-09-27
EP2892999A1 (en) 2015-07-15
US20150376570A1 (en) 2015-12-31
RU2015107036A (en) 2016-10-27

Similar Documents

Publication Publication Date Title
HUS2100012I1 (en) 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors
HK1212384A1 (en) Methods and compositions for producing induced hepatocytes
IL271305B (en) Anti-ntb-a antibodies and related compositions and methods
EP2836212A4 (en) Novel compositions and methods
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
IL236158A0 (en) Methods and compositions for biomethane production
IL237916A0 (en) Compositions and methods for producing glycoproteins
HK1206970A1 (en) Antigenic compositions and methods
GB201315350D0 (en) Methods and compositions
SG11201408326TA (en) Preparation method for perfluoro-2-methyl-3-pentanone and intermediate
GB201315347D0 (en) Methods and compositions
EP2802621A4 (en) Binder compositions and methods for making and using same
EP2931280A4 (en) Methods and compositions for inhibiting cnksr1
EP2852662A4 (en) Herpesvirus compositions and related methods
ZA201308892B (en) Compositions and methods
EP2837624A4 (en) 4-substituent-2-hydroxylmorpholine-3-one and preparation method thereof
EP2766357A4 (en) Meso-biliverdin compositions and methods
HK1231520A1 (en) Improved matrix stability compositions and methods
GB201222820D0 (en) Woolscouring method and composition
GB201206859D0 (en) Method and composition
ZA201500172B (en) Plant-disease-control composition and plant-disease-control method
GB201222736D0 (en) Composition and process
GB201116340D0 (en) Compositions and methods
GB201222810D0 (en) Woolscouring method and composition
GB201204512D0 (en) Method and composition